Sitawalk-D 100/10 Tablets

Composition: Dapagliflozin 10mg + Sitagliptin 100mg
MRP: ₹2600/-
Marketed by: Biophar Group, Division of Biophar Lifesciences Pvt Ltd

Introduction

Managing Type 2 Diabetes Mellitus (T2DM) effectively requires more than just glucose-lowering medication. It calls for a holistic and strategic treatment approach. Sitawalk-D 100/10 Tablets, a modern fixed-dose combination, addresses this need. It brings together Dapagliflozin 10mg and Sitagliptin 100mg, two well-researched molecules with complementary mechanisms.

Biophar Group, a division of Biophar Lifesciences Pvt Ltd, offers this formulation to bridge the gap between monotherapy limitations and multidrug convenience. As a result, Sitawalk-D 100/10 ensures broader and more effective glycemic control for patients who need more than a single-drug regimen.

Composition and Mechanism of Action

1. Dapagliflozin (10mg)

Dapagliflozin belongs to the class of SGLT2 inhibitors, which work by blocking glucose reabsorption in the kidneys. Consequently, the body excretes excess glucose through urine.

Moreover, it significantly reduces fasting and postprandial blood sugar.
It also supports weight loss and lowers blood pressure.
In addition, it has demonstrated cardiovascular benefits in patients with heart failure risks.

2. Sitagliptin (100mg)

Sitagliptin acts as a DPP-4 inhibitor that enhances the activity of incretin hormones like GLP-1 and GIP. These hormones stimulate insulin release and reduce glucagon secretion, especially after meals.

As a result, it improves post-meal glucose regulation.
Furthermore, it helps maintain consistent blood glucose levels throughout the day.
Unlike sulfonylureas, it reduces the risk of hypoglycemia.

Together, both ingredients work in synergy to target different aspects of glucose control, providing improved outcomes compared to monotherapy. PCD Pharma Franchise in West Bengal

Indications

Doctors prescribe Sitawalk-D 100/10 for several scenarios:

Primarily, it suits adults with Type 2 Diabetes Mellitus who do not achieve adequate glycemic control through monotherapy.
Additionally, it offers an oral alternative to injectable therapies for patients seeking convenience.
In particular, it benefits overweight diabetic individuals by supporting weight management alongside blood sugar control.

However, it is not suitable for individuals with Type 1 Diabetes or for managing diabetic ketoacidosis.

Key Benefits

Sitawalk-D 100/10 provides a wide range of clinical advantages:

1. Dual Action for Better Glycemic Control

By addressing both insulin secretion and glucose excretion, this combination ensures more comprehensive sugar regulation.

2. Supports Weight Management

Unlike many traditional antidiabetics, this formulation contributes to weight reduction, which is particularly valuable for obese or overweight diabetic patients.

3. Improves Cardiovascular Outcomes

Dapagliflozin has shown impressive results in reducing heart failure risks. Consequently, patients receive both glycemic and heart-related benefits.

4. Minimizes Risk of Hypoglycemia

Because it doesn’t rely on forced insulin release, Sitawalk-D reduces the likelihood of sudden blood sugar drops. Therefore, it is safer for elderly or high-risk individuals.

5. Reduces HbA1c Levels Effectively

Clinical data confirms that this combination helps lower HbA1c significantly over 12 to 24 weeks. This indicates strong long-term control.

6. Improves Treatment Adherence

Patients need to take only one tablet a day, which simplifies treatment and boosts compliance.

PCD Pharma Franchise in West Bengal

Dosage and Administration

Typically, the recommended dose is one tablet daily, preferably taken in the morning.
Patients can take it with or without food, depending on comfort and convenience.
However, those with kidney or liver issues should undergo proper evaluation before starting treatment.
For safety, healthcare providers should monitor renal function regularly.

Possible Side Effects

While most patients tolerate Sitawalk-D well, a few may experience mild side effects:

Frequent urination
Urinary or genital infections
Headaches or digestive discomfort

On the other hand, some rare but serious effects may include:

Diabetic ketoacidosis
Acute kidney injury
Severe dehydration

In such cases, patients should stop using the medication and contact their doctor immediately. Early identification of symptoms ensures safe continuation or discontinuation when necessary. Sitawalk-D 100/10 provides a wide range of clinical advantages

Precautions and Warnings

Doctors and patients should keep the following points in mind:

Renal Function: Patients with impaired kidney function may not receive full benefits from Dapagliflozin.
Liver Monitoring: Though Sitagliptin is safe in most cases, patients undergoing long-term therapy should check liver enzymes periodically.
Hydration: Encourage patients to drink enough fluids, especially in hot climates or during physical activity.
Pregnancy and Lactation: Use only when clearly necessary, as safety during these stages remains unestablished.
Surgical or Emergency Conditions: Temporary suspension may be needed during infections, surgery, or hospitalizations.

Storage Instructions

Store Sitawalk-D 100/10 tablets in a cool and dry environment, away from direct sunlight.
Keep the product in its original packaging to avoid moisture exposure.
Ensure children do not have access to the medication.
Always check the expiry date before consumption.

Why Choose Sitawalk-D 100/10 from Biophar Group?

Biophar Group has consistently delivered high-quality, affordable, and effective pharmaceutical products. Here’s why Sitawalk-D 100/10 is a top choice:

Manufactured in WHO-GMP-certified facilities, ensuring global quality standards.
Contains clinically backed molecules, offering reliable and well-tolerated treatment.
Uses premium ingredients and packaging, which guarantees safety and product longevity.
Moreover, Biophar provides extensive franchise and promotional support to its partners.
Therefore, doctors, patients, and pharma business owners trust this brand for performance and dependability.

MRP and Packaging

MRP: ₹2600/-
Packaging: High-quality aluminum blister strips for durability and hygiene
Details: Each strip is labeled with clear usage instructions and expiry details

This level of care in packaging reflects Biophar’s commitment to product safety and user convenience.

Franchise and Marketing Support

Biophar Group extends strong business support to PCD pharma franchise partners:

Visual aids, sample kits, and product literature are provided to boost market presence.
Territorial monopoly rights help partners grow their business in exclusive regions.
Prompt deliveries and consistent supply prevent stock shortages.
Training and updates ensure partners stay informed about new product developments.

As a result, Sitawalk-D 100/10 not only benefits patients but also empowers business owners to scale confidently in the anti-diabetic segment.

Join the Best PCD Pharma Franchise in India with Full Marketing Support

Explore a golden opportunity to start your own pharma business with India’s most trusted PCD Pharma Franchise. We offer 100% marketing support, including promotional materials, visual aids, MR bags, samples, and monopoly rights. Our wide range of high-quality, DCGI-approved products ensures strong market demand and better profit margins. With timely delivery, transparent dealings, and complete partner support, we help you grow faster and stronger in the competitive pharma sector.

Start your successful journey today with the most reliable name in the pharmaceutical industry.
Partner with us – Your growth is our priority!

Conclusion

To conclude, Sitawalk-D 100/10 Tablets offer a scientifically advanced, patient-friendly, and business-ready solution for managing Type 2 Diabetes. The combination of Dapagliflozin and Sitagliptin improves glycemic control, enhances heart health, supports weight loss, and ensures safety with a low risk of hypoglycemia.

Doctors looking for comprehensive diabetic treatment can confidently prescribe Sitawalk-D 100/10. At the same time, pharma franchise owners can depend on Biophar’s quality assurance, brand strength, and marketing support to grow in a competitive market.

Interested in Franchise or Distribution?

Email Id: biophar.purchase@gmail.com
📞 Call: 9888871967
🌐 Visit: www.biophargroup.com

📍 Available pan-India for PCD Pharma Franchise and Third Party Manufacturing

Contact Us